Here’s what you need to know:
1. Pharmacogenetic testing is a personalized approach to medicine. It allows anesthesiologists to tailor anesthesia medication based on a patient’s genetic data.
2. By analyzing a patient’s genetic composition, anesthesiologists can predict which drugs a patient may react poorly to. This could prove useful for identifying patients at risk of opioid addiction.
3. However, some say more research on pharmacogenetics is necessary before physicians tout the benefits of this testing technique.
4. Reimbursement for pharmacogenetics is a challenge. Last year, Medicare discontinued payment for some pharmacogenetic testing.
5. Regardless, Mr. Mira concludes: “pharmacogenomics is unlikely to disappear and anesthesiologists would be wise to keep it on their radars.”
More articles on anesthesia:
Andrea Cameron named Metropolitan Anesthesia Consultants’ new COO: 3 notes
Global market for anesthetic, respiratory devices to reach $24.2B by 2020: 3 notes
AANA, Middle Tennessee School of Anesthesia develop fellowship: 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
